Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An autosomal recessive muscular dystrophy caused by mutations in the POMGNT1 gene. It is associated with characteristic brain and eye malformations, profound mental retardation, and death usually in the first years of life.
Features include always present findings: Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration), Generalized hypotonia, Short nasal bridge, and Hydrocephalus and others; and common findings: Seizure. 50 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 10 | Opacification of the corneal stroma, Strabismus, Cataract |
Brain and nerves | 10 | Seizure, Profound intellectual disability, Hydrocephalus |
Muscles | 7 | Severe muscular hypotonia, Generalized hypotonia, Muscle weakness |
Head and neck | 2 | Microcephaly, Everted lower lip vermilion |
Lab test results | 1 | Elevated creatine kinase (muscle enzyme) (elevated circulating creatine kinase concentration) |
Age of onset: at birth.
POMGNT1 function has not been fully characterized.
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 is associated with mutations in the POMGNT1 gene on chromosome 1.
Genetic testing for POMGNT1 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3 has been reported in the published literature.
Phenotype severity distribution: 10 always present features, 1 common feature.
No clinical trials have been registered for muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3.
120 publications have been identified in PubMed for muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A3. Kisho has analyzed 85 by research type. Research spans Review / Meta-Analysis (34%), Epidemiology / Natural History (25%), and Other (24%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 29 | 34% |
Disease patterns and progression | 21 | 25% |
Other research | 20 | 24% |
Clinical study results | 7 | 8% |
Laboratory research | 7 | 8% |
Testing and diagnosis research | 1 | 1% |
Hao Y (2026). [PMID: 41267400](https://pubmed.ncbi.nlm.nih.gov/41267400/). *HGG advances*. [Diagnostic / Biomarker]
Li S (2026). [PMID: 41379706](https://pubmed.ncbi.nlm.nih.gov/41379706/). *J Fam Psychol*. [Review / Meta-Analysis]
Cyriac J (2026). [PMID: 41324838](https://pubmed.ncbi.nlm.nih.gov/41324838/). *Journal of religion and health*. [Review / Meta-Analysis]
Onur D (2026). [PMID: 41861182](https://pubmed.ncbi.nlm.nih.gov/41861182/). *Medicine*. [Epidemiology / Natural History]
Smith M (2026). [PMID: 41421115](https://pubmed.ncbi.nlm.nih.gov/41421115/). *Acta psychologica*. [Basic Science / Preclinical]
Donohue GF (2026). [PMID: 41793381](https://pubmed.ncbi.nlm.nih.gov/41793381/). *European journal of pain (London, England)*. [Review / Meta-Analysis]
Leach L (2025). [PMID: 40610977](https://pubmed.ncbi.nlm.nih.gov/40610977/). *BMC public health*. [Epidemiology / Natural History]
Totenhagen CJ (2025). [PMID: 39779458](https://pubmed.ncbi.nlm.nih.gov/39779458/). *Family process*. [Review / Meta-Analysis]
Leavitt CE (2025). [PMID: 39985402](https://pubmed.ncbi.nlm.nih.gov/39985402/). *Journal of sex & marital therapy*. [Epidemiology / Natural History]
Svop K (2025). [PMID: 40187033](https://pubmed.ncbi.nlm.nih.gov/40187033/). *Eur J Oncol Nurs*. [Other]
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center